article thumbnail

Type 1 Diabetes Vaccine: Does Diamyd Have a Winning Formula?

XTalks

A vaccine developed by Swedish company Diamyd Medical has demonstrated significant treatment efficacy in a predefined genetic subgroup of individuals with type 1 diabetes in a Phase IIb clinical trial. In the trial, the vaccine was injected directly into the lymph nodes of type 1 diabetic individuals.

Vaccine 103
article thumbnail

“Patients are only numbers on an Excel spreadsheet”

World of DTC Marketing

” According to data from the People’s Vaccine Alliance, Pfizer, BioNTech, and Moderna make $65k a minute in combined profits from their vaccines, based on profits reported in the three companies’ latest reports. Today pharma is about “business.”

Insulin 259
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Looking back at 2022: The top healthcare stories

Pharmaceutical Technology

Reynald Castaneda wrote about the affected clinical trial ecosystems in both countries , while Fiona Barry and Manasi analysed the impact of the war on the supply of the Russian Covid-19 vaccine Sputnik V to the rest of the world.

article thumbnail

Phase 3 trial dashes Oramed’s oral insulin hopes

pharmaphorum

Oramed Pharma has conceded defeat in its attempt to bring an oral formulation of insulin to market for people with type 2 diabetes, after its ORMD-0801 candidate missed the mark in a phase 3 trial. The post Phase 3 trial dashes Oramed’s oral insulin hopes appeared first on.

Insulin 59
article thumbnail

Researchers Develop Arthritis Vaccine + Medtronic Expands Recall on Insulin Pumps – Xtalks Life Science Podcast Ep. 32

XTalks

In addition to timely diagnosis, there may soon be a preventative vaccine for inflammatory arthritic conditions such as rheumatoid arthritis. Researchers at the University of Toledo have developed a vaccine against inflammatory arthritis that has shown promise in animal models. The recalls affect almost half a million devices combined.

Insulin 45
article thumbnail

WHO announces international hub for mRNA vaccine training

pharmaphorum

The World Health Organization (WHO) announced the opening of a global biomanufacturing hub located in South Korea to provide training to low- and middle-income countries seeking to produce vaccines and other biologics, such as insulin and monoclonal antibodies. . of individuals in low-income countries have received their first dose.

Vaccine 98
article thumbnail

Arecor hopes London stock market float will raise profile of insulin products

pharmaphorum

UK biotech Arecor Therapeutics has announced plans to float on the London stock market, to fund plans to develop novel formulations of insulins and other biological drugs with enhanced properties. The initial therapeutic focus is diabetes, with three insulin-based products in development.

Insulin 52